Review explores how science is making strides in DMD diagnosis and treatment
New technologies are helping doctors better understand Duchenne muscular dystrophy and leading to better diagnosis and treatment options.
News
-
-
CRISPR gene editing offers new hope for treating Duchenne
CRISPR shows promise in correcting DMD mutations and restoring dystrophin, and future patients may benefit from personalized strategies.
-
New research compares corticosteroid dosing regimens for DMD
Intermittent prednisone increased the risk of cushingoid appearance, excess hair growth and high blood pressure in patients with DMD.
-
How virtual reality may change DMD rehabilitation treatment
Virtual reality (VR) is becoming a promising tool in the rehab toolbox for people with Duchenne muscular dystrophy (DMD).
-
Review identifies what physical activity really means to people with DMD
For people with DMD, physical activity is about more than walking, with independence and quality of life tied to meaningful movement.
-
Scoliosis-correcting surgery could improve survival in DMD
Scoliosis-correcting surgery may prolong survival in patients with Duchenne muscular dystrophy (DMD), according to study.
-
New research identifies inhibiting EZH2 as potential DMD treatment
A new study found that blocking the protein EZH2 with an inhibitor drug improved muscle health and function in mice with DMD.
-
New genetic therapy shows promise in improving muscle health in DMD
A new genetic therapy, WVE-N531, has shown promise in improving muscle health in boys with Duchenne muscular dystrophy (DMD).
-
Study finds no clear benefit in heart function from starting cardiac drugs early in DMD
Starting heart medications early in boys with Duchenne muscular dystrophy (DMD) did not prevent the heart’s decline over five years.
-
Case study examines nighttime ventilation in patients with both DMD and autism
A recent case study shows the challenges of initiating non-invasive ventilation (NIV) in patients with DMD and neurocognitive comorbidities.
